Premium
Soluble CD23 (sCD23) serum levels and lymphocyte subpopulations in peripheral blood in rhinitis and extrinsic and intrinsic asthma
Author(s) -
SánchezGuerrero I.,
Albaladejo M. D.,
GarcíaAlonso A. M.,
Muro M.,
Hernández J.,
Alvarez M. R.
Publication year - 1994
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/j.1398-9995.1994.tb00123.x
Subject(s) - cd23 , immunology , immunoglobulin e , asthma , medicine , monocyte , allergy , peripheral blood , lymphocyte , immunopathology , antibody
To determine serum levels of IgE and sCD23 and lymphocyte subpopulations, we studied 37 control subjects and 84 patients (27 with allergic rhinitis, 27 with extrinsic asthma, and 30 with intrinsic asthma). A rise in surface CD23 on B and monocyte cells and sCD23 serum levels was exhibited by patients with rhinitis and extrinsic asthma. Unexpectedly, in intrinsic asthmatic patients, high CD23 expression on monocytes and high sCD23 levels were seen that did not result in IgE production. It appears that CD23, in its soluble form, could be a good disease marker, especially in asthma. Atopic patients yielded a significantly lower proportion of CD4 + T cells than intrinsic asthmatic patients and normal persons. Otherwise, CD4 + CD29 + CD45RA ‐ and CD4 + CD29 – CD45RA + T‐cell subsets were significantly decreased in all patient groups.